Want to see BDTX full AI Analyst Report?
Black Diamond Therapeutics (BDTX) Ownership Overview
9.06% Insiders
17.25% Mutual Funds
0.27% Other Institutional Investors
10.04% ETFs
63.38% Public Companies and
Individual Investors
The ownership structure of Black Diamond Therapeutics (BDTX) stock is a mix of institutional, retail, and individual investors. Approximately 27.56% of the company’s stock is owned by Institutional Investors, 9.06% is owned by Insiders, and 63.38% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $364015 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $35850 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,551,286 | Insider | 7.94% | 8,146,802 | |
| 2,646,444 | Institution | 4.62% | 4,737,135 | |
| 2,381,395 | Institution | 4.16% | 4,262,697 | |
| 2,130,050 | Institution | 3.72% | 3,812,790 | |
| 1,827,988 | Institution | 3.19% | 3,272,099 | |
| 1,792,699 | Institution | 3.13% | 3,208,931 | |
| 1,396,549 | Institution | 2.44% | 2,499,823 | |
| 604,401 | Institution | 1.05% | 1,081,878 | |
| 549,973 | Institution | 0.96% | 984,452 | |
| 483,000 | Institution | 0.84% | 864,570 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,646,444 | Institution | 4.62% | 4,737,135 | |
| 2,130,050 | Institution | 3.72% | 3,812,790 | |
| 1,792,699 | Institution | 3.13% | 3,208,931 | |
| 1,396,549 | Institution | 2.44% | 2,499,823 | |
| 604,401 | Institution | 1.05% | 1,081,878 | |
| 483,000 | Institution | 0.84% | 864,570 | |
| 452,967 | Institution | 0.79% | 810,811 | |
| 152,352 | Institution | 0.27% | 272,710 | |
| 51,500 | Institution | 0.09% | 92,185 | |
| 41,761 | Institution | 0.07% | 74,752 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,556,251 | Institution | 2.72% | 2,879,064 | |
| 1,221,665 | Institution | 2.13% | 2,186,780 | |
| 551,275 | Institution | 0.96% | 986,782 | |
| 511,250 | Institution | 0.89% | 945,813 | |
| 359,458 | Institution | 0.63% | 643,430 | |
| 272,839 | Institution | 0.48% | 504,752 | |
| 253,266 | Institution | 0.44% | 458,411 | |
| 210,208 | Institution | 0.37% | 376,272 | |
| 160,531 | Institution | 0.28% | 287,350 | |
| 94,001 | Institution | 0.16% | 168,262 |
FAQ
Who Owns Black Diamond Therapeutics, Inc. (BDTX)?
According to the latest TipRanks data, approximately 0.27% of the company's stock is held by institutional investors, 9.06% is held by insiders, and 63.38% is held by retail investors.
What percentage of Black Diamond Therapeutics, Inc. (BDTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.27% of Black Diamond Therapeutics, Inc. (BDTX) stock is held by institutional investors.
What percentage of Black Diamond Therapeutics, Inc. (BDTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 63.38% of Black Diamond Therapeutics, Inc. (BDTX) stock is held by retail investors.
Who owns the most shares of Black Diamond Therapeutics, Inc. (BDTX)?
Ali Behbahani owns the most shares of Black Diamond Therapeutics, Inc. (BDTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.